Wealthspire Advisors (Maryland)’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,072
Closed -$53K – 1856
2019
Q1
$53K Buy
1,072
+440
+70% +$19.8K ﹤0.01% 876
2018
Q4
$23K Buy
632
+152
+32% +$6.35K ﹤0.01% 1153
2018
Q3
$24K Hold
480
– – ﹤0.01% 1236
2018
Q2
$18K Buy
480
+24
+5% +$916 ﹤0.01% 1357
2018
Q1
$17K Sell
456
-196
-30% -$6.92K ﹤0.01% 1352
2017
Q4
$21K Buy
652
+40
+7% +$1.27K ﹤0.01% 1311
2017
Q3
$18K Buy
612
+64
+12% +$1.9K ﹤0.01% 1337
2017
Q2
$16K Buy
548
+168
+44% +$4.59K ﹤0.01% 1350
2017
Q1
$10K Hold
380
– – ﹤0.01% 1350
2016
Q4
$10K Sell
380
-180
-32% -$4.73K ﹤0.01% 1231
2016
Q3
$15K Hold
560
– – ﹤0.01% 1147
2016
Q2
$16K Hold
560
– – ﹤0.01% 1079
2016
Q1
$13K Hold
560
– – ﹤0.01% 1125
2015
Q4
$13K Buy
+560
New +$12.8K ﹤0.01% 1121

Other funds holding TECH

Wealthspire Advisors (Maryland)'s TECH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 1,072 shares — an estimated $53K sold.

Wealthspire Advisors (Maryland) first reported a position in TECH in Q4 2015 and held it in 14 quarters. The position peaked at $53K in Q1 2019. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,072 Bio-Techne shares in Q2 2019, an estimated $53K.
  • Wealthspire Advisors (Maryland) first reported a position in Bio-Techne in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Bio-Techne position peaked at $53K in Q1 2019.
  • 369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.